Quality providers offer ongoing consultation as protocols evolve
Rights and permissions Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( which permits unrestricted use, distribution and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made
Liver disease The issue Up to 70 percent of people with Type 2 diabetes and between 50 and 90 percent of people with obesity have nonalcoholic fatty liver disease, or NAFLD, which occurs when excess fat builds up in the liver
Ozempic and Wegovy contain semaglutide, but they have different labeled uses
Part of the retatrutide guide
GLP-1 receptor agonists are used for type 2 diabetes and weight loss, and mimic the way the naturally occurring hormone, GLP-1, acts in the body